|
| 37793701 | UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment. | Br J Clin Pharmacol | 2024 |
| 37793701 | UK Prescribing Safety Assessment (PSA): The development, implementation and outcomes of a national online prescribing assessment. | Br J Clin Pharmacol | 2024 |
| 36808131 | Equal access to pharmacogenomics testing: The ethical imperative for population-wide access in the UK NHS. | Br J Clin Pharmacol | 2023 |
| 37828025 | ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon. | Nat Commun | 2023 |
| 37816352 | Functional filter for whole-genome sequencing data identifies HHT and stress-associated non-coding SMAD4 polyadenylation site variants >5 kb from coding DNA. | Am J Hum Genet | 2023 |
| 37907686 | British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis. | Pharmacogenomics J | 2023 |
| 37810217 | Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohort. | iScience | 2023 |
| 37808344 | <i>CYP2C19</i> Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel. | JACC Adv | 2023 |
| 36972688 | Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure. | Eur Heart J | 2023 |
| 37211972 | Precision medicine in rare diseases: What is next? | J Intern Med | 2023 |
| 37461547 | POPULATION FREQUENCY OF REPEAT EXPANSIONS INDICATES INCREASED DISEASE PREVALENCE ESTIMATES ACROSS DIFFERENT POPULATIONS. | medRxiv | 2023 |
| 37143396 | CYP2C19 loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British-South Asian cohort. | Br J Clin Pharmacol | 2023 |
| 36808131 | Equal access to pharmacogenomics testing: The ethical imperative for population-wide access in the UK NHS. | Br J Clin Pharmacol | 2023 |
| 36926444 | Poverty dynamics and the determining factors among East African smallholder farmers. | Agric Syst | 2023 |
| 37221222 | SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort. | Pharmacogenomics J | 2023 |
| 37808344 | <i>CYP2C19</i> Genotype Prevalence and Association With Recurrent Myocardial Infarction in British-South Asians Treated With Clopidogrel. | JACC Adv | 2023 |
| 37907686 | British South Asian ancestry participants views of pharmacogenomics clinical implementation and research: a thematic analysis. | Pharmacogenomics J | 2023 |
| 37828025 | ADRA2A and IRX1 are putative risk genes for Raynaud's phenomenon. | Nat Commun | 2023 |
| 37816352 | Functional filter for whole-genome sequencing data identifies HHT and stress-associated non-coding SMAD4 polyadenylation site variants >5 kb from coding DNA. | Am J Hum Genet | 2023 |
| 37810217 | Factor V Leiden, estrogen, and multimorbidity association with venous thromboembolism in a British-South Asian cohort. | iScience | 2023 |
| 37461547 | POPULATION FREQUENCY OF REPEAT EXPANSIONS INDICATES INCREASED DISEASE PREVALENCE ESTIMATES ACROSS DIFFERENT POPULATIONS. | medRxiv | 2023 |
| 37221222 | SLCO1B1*5 is protective against non-senile cataracts in cohort prescribed statins: analysis in a British-South Asian cohort. | Pharmacogenomics J | 2023 |
| 37211972 | Precision medicine in rare diseases: What is next? | J Intern Med | 2023 |
| 37143396 | CYP2C19 loss-of-function alleles are not associated with higher prevalence of gastrointestinal bleeds in those who have been prescribed antidepressants: Analysis in a British-South Asian cohort. | Br J Clin Pharmacol | 2023 |
| 36972688 | Genetic analyses identify brain structures related to cognitive impairment associated with elevated blood pressure. | Eur Heart J | 2023 |
| 36926444 | Poverty dynamics and the determining factors among East African smallholder farmers. | Agric Syst | 2023 |
| 34463331 | Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 36333502 | Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. | Nat Genet | 2022 |
| 35363781 | Heteroplasmic mitochondrial DNA variants in cardiovascular diseases. | PLoS Genet | 2022 |
| 36198798 | Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes. | Nature | 2022 |
| 33638977 | The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 34463331 | Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 34904380 | Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. | Am J Med Genet A | 2022 |
| 35162696 | Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare. | Int J Environ Res Public Health | 2022 |
| 35069183 | The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction. | Front Pharmacol | 2022 |
| 35363781 | Heteroplasmic mitochondrial DNA variants in cardiovascular diseases. | PLoS Genet | 2022 |
| 36333502 | Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. | Nat Genet | 2022 |
| 36198798 | Nuclear-embedded mitochondrial DNA sequences in 66,083 human genomes. | Nature | 2022 |
| 33638977 | The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. | Eur Heart J Cardiovasc Pharmacother | 2022 |
| 35162696 | Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare. | Int J Environ Res Public Health | 2022 |
| 35069183 | The Pharmacogenetics of Statin Therapy on Clinical Events: No Evidence that Genetic Variation Affects Statin Response on Myocardial Infarction. | Front Pharmacol | 2022 |
| 34904380 | Identification and validation of a novel pathogenic variant in GDF2 (BMP9) responsible for hereditary hemorrhagic telangiectasia and pulmonary arteriovenous malformations. | Am J Med Genet A | 2022 |
| 33350578 | An online compendium of treatable genetic disorders. | Am J Med Genet C Semin Med Genet | 2021 |
| 34231218 | Adverse Cardiovascular Outcomes and Antihypertensive Treatment: A Genome-Wide Interaction Meta-Analysis in the International Consortium for Antihypertensive Pharmacogenomics Studies. | Clin Pharmacol Ther | 2021 |
| 33958779 | Uncovering genetic mechanisms of hypertension through multi-omic analysis of the kidney. | Nat Genet | 2021 |
| 34115965 | Pan-ancestry exome-wide association analyses of COVID-19 outcomes in 586,157 individuals. | Am J Hum Genet | 2021 |
| 33727701 | Publisher Correction: Discovery of rare variants associated with blood pressure regulation through meta-analysis of 1.3 million individuals. | Nat Genet | 2021 |
| 33977903 | The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London. | Int J Tuberc Lung Dis | 2021 |
| 34329581 | Scaling national and international improvement in virtual gene panel curation via a collaborative approach to discordance resolution. | Am J Hum Genet | 2021 |
| 33307546 | Genetic mechanisms of critical illness in COVID-19. | Nature | 2021 |